Analystreport

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $8.00 to $7.00. They now have a "neutral"

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com